{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:54:24Z","timestamp":1783464864178,"version":"3.55.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001153","name":"George and Mary Josephine Hamman Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001153","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL151737"],"award-info":[{"award-number":["R01 HL151737"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["S10 OD018135"],"award-info":[{"award-number":["S10 OD018135"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL132401"],"award-info":[{"award-number":["R01 HL132401"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001173","name":"Greater Houston Community Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001173","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"publisher","award":["14 CVD 03"],"award-info":[{"award-number":["14 CVD 03"]}],"id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Pathology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.carpath.2020.107278","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T23:42:13Z","timestamp":1599003733000},"page":"107278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["Current state of vaccine development and targeted therapies for COVID-19: impact of basic science discoveries"],"prefix":"10.1016","volume":"50","author":[{"given":"Ali J.","family":"Marian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carpath.2020.107278_bib0001","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.carpath.2020.107278_bib0002","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.carpath.2020.107278_bib0003","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.sbi.2005.10.004","article-title":"Structural insights into SARS coronavirus proteins","volume":"15","author":"Bartlam","year":"2005","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.carpath.2020.107278_bib0004","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.carpath.2020.107278_bib0005","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.carpath.2020.107278_bib0006","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1128\/JVI.01467-06","article-title":"A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo","volume":"81","author":"DeDiego","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.carpath.2020.107278_bib0007","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.carpath.2020.107278_bib0008","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.coviro.2012.04.004","article-title":"SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon","volume":"2","author":"Totura","year":"2012","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.carpath.2020.107278_bib0009","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1161\/CIRCRESAHA.113.301271","article-title":"The discovery of the ACE2 gene","volume":"112","author":"Marian","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.carpath.2020.107278_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101212","article-title":"Proteolytic cleavage of the SARS-CoV-2 spike protein and the role of the novel S1\/S2 site","volume":"23","author":"Jaimes","year":"2020","journal-title":"iScience."},{"key":"10.1016\/j.carpath.2020.107278_bib0011","first-page":"3","article-title":"TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells","author":"Bestle","year":"2020","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.carpath.2020.107278_bib0012","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.carpath.2020.107278_bib0013","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1128\/JVI.02202-13","article-title":"TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein","volume":"88","author":"Heurich","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.carpath.2020.107278_bib0014","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues","volume":"181","author":"Ziegler","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.carpath.2020.107278_bib0015","doi-asserted-by":"crossref","DOI":"10.15252\/embj.20105114","article-title":"SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells","volume":"39","author":"Lukassen","year":"2020","journal-title":"EMBO J"},{"key":"10.1016\/j.carpath.2020.107278_bib0016","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH743>3.0.CO;2-T","article-title":"Expression of transmembrane serine protease TMPRSS2 in mouse and human tissues","volume":"193","author":"Vaarala","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.carpath.2020.107278_bib0017","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/cvr\/cvaa106","article-title":"COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options","volume":"116","author":"Guzik","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.carpath.2020.107278_bib0018","article-title":"An inflammatory cytokine signature helps predict COVID-19 severity and death","author":"Del Valle","year":"2020","journal-title":"medRxiv."},{"key":"10.1016\/j.carpath.2020.107278_bib0019","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/j.jinf.2020.03.027","article-title":"Herd immunity - estimating the level required to halt the COVID-19 epidemics in affected countries","volume":"80","author":"Kwok","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.carpath.2020.107278_bib0020","article-title":"Genomewide association study of severe Covid-19 with respiratory failure","author":"Ellinghaus","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carpath.2020.107278_sbref0021","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-020-00433-7","article-title":"Shared CD8(+) T cell receptors for SARS-CoV-2","author":"Levantovsky","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.carpath.2020.107278_bib0022","article-title":"Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels","author":"Snyder","year":"2020","journal-title":"medRxiv."},{"issue":"13","key":"10.1016\/j.carpath.2020.107278_bib0023","doi-asserted-by":"crossref","first-page":"e00510","DOI":"10.1128\/JVI.00510-20","article-title":"Human leukocyte antigen susceptibility map for severe acute respiratory syndrome coronavirus 2","volume":"94","author":"Nguyen","year":"2020","journal-title":"J Virol"},{"issue":"20","key":"10.1016\/j.carpath.2020.107278_bib0024","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.carpath.2020.107278_bib0025","first-page":"30316","article-title":"Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study","volume":"S2213-2600","author":"Karagiannidis","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"8","key":"10.1016\/j.carpath.2020.107278_bib0026","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s40520-020-01631-y","article-title":"COVID-19 and the elderly: insights into pathogenesis and clinical decision-making","volume":"32","author":"Perrotta","year":"2020","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.carpath.2020.107278_bib0027","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41467-020-14396-9","article-title":"Sexual-dimorphism in human immune system aging","volume":"11","author":"Marquez","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.carpath.2020.107278_bib0028","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13293-020-00304-9","article-title":"Impact of sex and gender on COVID-19 outcomes in Europe","volume":"11","author":"Gebhard","year":"2020","journal-title":"Biol Sex Differ"},{"key":"10.1016\/j.carpath.2020.107278_bib0029","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1038\/s41467-019-12348-6","article-title":"ImmGen report: sexual dimorphism in the immune system transcriptome","volume":"10","author":"Gal-Oz","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.carpath.2020.107278_bib0030","first-page":"4180","article-title":"Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2","volume":"59","author":"Lin","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.carpath.2020.107278_bib0031","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/cvr\/cvaa191","article-title":"Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart","volume":"116","author":"Liu","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.carpath.2020.107278_bib0032","first-page":"708","article-title":"Myocyte-specific upregulation of ACE2 in cardiovascular disease: implications for SARS-CoV-2-mediated myocarditis","volume":"142","author":"Tucker","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2020.107278_bib0033","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1161\/CIRCRESAHA.120.317055","article-title":"COVID-19 and the heart","volume":"126","author":"Akhmerov","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.carpath.2020.107278_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.carpath.2020.107233","article-title":"The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities","volume":"48","author":"Buja","year":"2020","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.carpath.2020.107278_bib0035","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13000-020-00999-9","article-title":"The spectrum of pathological findings in coronavirus disease (COVID-19) and the pathogenesis of SARS-CoV-2","volume":"15","author":"Barth","year":"2020","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.carpath.2020.107278_bib0036","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/eurheartj\/ehaa388","article-title":"Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy","volume":"41","author":"Inciardi","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carpath.2020.107278_bib0037","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/eurheartj\/ehaa408","article-title":"Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019","volume":"41","author":"Shi","year":"2020","journal-title":"Eur Heart J."},{"issue":"8","key":"10.1016\/j.carpath.2020.107278_bib0038","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/jama.2020.13372","article-title":"Thrombosis in hospitalized patients with COVID-19 in a New York City health system","volume":"324","author":"Bilaloglu","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.carpath.2020.107278_bib0039","doi-asserted-by":"crossref","DOI":"10.1111\/ejh.13501","article-title":"COVID-19 coagulopathy: an in-depth analysis of the coagulation system","author":"Martin-Rojas","year":"2020","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.carpath.2020.107278_bib0040","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood.2020006520","article-title":"COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection","volume":"136","author":"Al-Samkari","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.carpath.2020.107278_bib0041","doi-asserted-by":"crossref","DOI":"10.1177\/1076029620948137","article-title":"COVID-19 associated coagulopathy and thrombotic complications","volume":"26","author":"Mezalek","year":"2020","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.carpath.2020.107278_bib0042","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.carpath.2020.107278_bib0043","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.abc5902","article-title":"Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability","volume":"369","author":"Brouwer","year":"2020","journal-title":"Science"},{"issue":"16","key":"10.1016\/j.carpath.2020.107278_bib0044","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 critically ill patients with COVID-19 with convalescent plasma","volume":"323","author":"Shen","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.carpath.2020.107278_bib0045","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1073\/pnas.2004168117","article-title":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients","volume":"117","author":"Duan","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.carpath.2020.107278_bib0046","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.10044","article-title":"Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial","author":"Li","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.carpath.2020.107278_bib0047","article-title":"Convalescent plasma for COVID-19. A randomized clinical trial","volume":"2020","author":"Gharbharan","year":"2020","journal-title":"medRxiv."},{"key":"10.1016\/j.carpath.2020.107278_bib0048","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003774","article-title":"Tmprss2 is essential for influenza H1N1 virus pathogenesis in mice","volume":"9","author":"Hatesuer","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.carpath.2020.107278_bib0049","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.1128\/AAC.01043-16","article-title":"Identification of nafamostat as a potent inhibitor of middle east respiratory syndrome coronavirus S protein-mediated membrane fusion using the split-protein-based cell-cell fusion assay","volume":"60","author":"Yamamoto","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.carpath.2020.107278_bib0050","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ijid.2020.05.072","article-title":"Three cases of treatment with nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy","volume":"96","author":"Jang","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.carpath.2020.107278_bib0051","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jcrc.2020.06.019","article-title":"Update I. A systematic review on the efficacy and safety of chloroquine\/hydroxychloroquine for COVID-19","volume":"59","author":"Cortegiani","year":"2020","journal-title":"J Crit Care"},{"key":"10.1016\/j.carpath.2020.107278_bib0052","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2019014","article-title":"Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19","author":"Cavalcanti","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carpath.2020.107278_bib0053","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s41591-020-0888-2","article-title":"The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin","volume":"26","author":"Chorin","year":"2020","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.carpath.2020.107278_bib0054","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cell.2020.05.034","article-title":"Structural basis for RNA replication by the SARS-CoV-2 polymerase","volume":"182","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.carpath.2020.107278_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104857","article-title":"A library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-19","volume":"180","author":"Jockusch","year":"2020","journal-title":"Antiviral Res"},{"issue":"10","key":"10.1016\/j.carpath.2020.107278_bib0056","first-page":"994","article-title":"Remdesivir for the treatment of Covid-19 - preliminary report","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carpath.2020.107278_bib0057","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.carpath.2020.107278_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104899","article-title":"Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: clinical outcome and differences in post-treatment hospitalisation status","volume":"158","author":"Antinori","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.carpath.2020.107278_bib0059","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.16349","article-title":"Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial","author":"Spinner","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.carpath.2020.107278_bib0060","article-title":"Experimental treatment with favipiravir for COVID-19: an open-label control study","author":"Cai","year":"2020","journal-title":"Engineering (Beijing)"},{"key":"10.1016\/j.carpath.2020.107278_bib0061","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/s13054-020-03137-5","article-title":"Effect of favipiravir and an anti-inflammatory strategy for COVID-19","volume":"24","author":"Yamamura","year":"2020","journal-title":"Crit Care"},{"issue":"541","key":"10.1016\/j.carpath.2020.107278_bib0062","doi-asserted-by":"crossref","first-page":"eabb5883","DOI":"10.1126\/scitranslmed.abb5883","article-title":"An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice","volume":"12","author":"Sheahan","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.carpath.2020.107278_bib0063","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of Lopinavir-Ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carpath.2020.107278_bib0064","doi-asserted-by":"crossref","first-page":"m2650","DOI":"10.1136\/bmj.m2650","article-title":"Covid-19: Lopinavir-Ritonavir does not benefit hospitalised patients, UK trial finds","volume":"370","author":"Griffin","year":"2020","journal-title":"BMJ."},{"issue":"5","key":"10.1016\/j.carpath.2020.107278_bib0065","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/infdis\/jiaa363","article-title":"Serum cytokine and chemokine profile in relation to the severity of coronavirus disease 2019 (COVID-19) in China","volume":"222","author":"Chi","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.carpath.2020.107278_bib0066","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.carpath.2020.107278_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/S2665-9913(20)30277-0","article-title":"Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study","author":"Biran","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.carpath.2020.107278_bib0068","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1016\/S2665-9913(20)30173-9","article-title":"Tocilizumab in patients with severe COVID-19: a retrospective cohort study","volume":"2","author":"Guaraldi","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.carpath.2020.107278_bib0069","article-title":"Dexamethasone in hospitalized patients with Covid-19 - preliminary report","author":"Group","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carpath.2020.107278_bib0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000896","article-title":"Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing","volume":"6","author":"Eckerle","year":"2010","journal-title":"PLoS Pathog"},{"issue":"4","key":"10.1016\/j.carpath.2020.107278_bib0071","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.carpath.2020.107278_bib0072","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.cell.2020.06.040","article-title":"Making sense of mutation: what D614G means for the COVID-19 pandemic remains unclear","volume":"182","author":"Grubaugh","year":"2020","journal-title":"Cell"},{"issue":"7821","key":"10.1016\/j.carpath.2020.107278_bib0073","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-020-2571-7","article-title":"Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike","volume":"584","author":"Liu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.carpath.2020.107278_bib0074","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.carpath.2020.107278_bib0075","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2 - preliminary report","author":"Jackson","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carpath.2020.107278_bib0076","article-title":"RNA-based COVID-19 vaccine BNT162b2 selected for a pivotal efficacy study","author":"Walsh","year":"2020","journal-title":"medRxiv."},{"issue":"6505","key":"10.1016\/j.carpath.2020.107278_bib0077","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1126\/science.abc6284","article-title":"DNA vaccine protection against SARS-CoV-2 in rhesus macaques","volume":"369","author":"Yu","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.carpath.2020.107278_bib0078","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(20)31208-3","article-title":"Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial","volume":"395","author":"Zhu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.carpath.2020.107278_bib0079","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1073\/pnas.91.10.4407","article-title":"Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy","volume":"91","author":"Yang","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.carpath.2020.107278_bib0080","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/sj.gt.3300412","article-title":"Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression","volume":"4","author":"Michou","year":"1997","journal-title":"Gene Ther"},{"key":"10.1016\/j.carpath.2020.107278_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102743","article-title":"Microneedle array delivered recombinant coronavirus vaccines: immunogenicity and rapid translational development","volume":"55","author":"Kim","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.carpath.2020.107278_bib0082","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.abc1932","article-title":"Development of an inactivated vaccine candidate for SARS-CoV-2","volume":"369","author":"Gao","year":"2020","journal-title":"Science"}],"container-title":["Cardiovascular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105488072030082X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105488072030082X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T16:27:48Z","timestamp":1762360068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105488072030082X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":82,"alternative-id":["S105488072030082X"],"URL":"https:\/\/doi.org\/10.1016\/j.carpath.2020.107278","relation":{},"ISSN":["1054-8807"],"issn-type":[{"value":"1054-8807","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current state of vaccine development and targeted therapies for COVID-19: impact of basic science discoveries","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carpath.2020.107278","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107278"}}